Newron
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (15)
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Started: 1/23/2026
Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
Started: 4/1/2009
Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain
Started: 3/20/2009
MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)
Started: 10/1/2009
Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Started: 2/1/2009
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
Started: 10/26/2016
Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
Started: 6/16/2020
A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging
Started: 3/1/2011
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
Started: 12/1/2015
Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
Started: 4/1/2010
A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease
Started: 9/1/2010
A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.
Started: 6/1/2013
A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics
Started: 9/1/2009
A Study to Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics
Started: 4/1/2009